The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus

Neuropharmacology

Volumn 37, Issue 10-11, 1998, Pages 1269-1277

  Vignes, M ^a,b   Clarke, V R J ^a   Parry, M J ^a   Bleakman, D ^c   Lodge, D ^c   Ornstein, P L ^c   Collingridge, G L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIV MONTPELLIER   (France)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

ATPA; EPSP; Hippocampus; Kainic acid; LY294486; Mossy fibre; Presynaptic receptor; Synaptic transmission

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1,2,3,4,4A,5,6,7,8,8A DECAHYDRO 6 (1H TETRAZOL 5 YLMETHOXYMETHYL) 3 ISOQUINOLINECARBOXYLIC ACID; KAINIC ACID RECEPTOR; PRESYNAPTIC RECEPTOR; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MOSSY FIBER; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

EID: 0032191263     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00148-8     Document Type: Conference Paper

References (39)

1. Agrawal, S.G., Evans, R.H., 1986. The primary afferent depolarizing action of kainate in the rat. Br. J. Pharmacol. 87, 345-355.
2. Anderson, W.W., Collingridge, G.L., 1997. A data acquisition program for on-line analysis of long-term potentiation and long-term depression. Soc. Neurosci. Abstr. 23, 665.
3. Bettler, B., Boulter, J., Hermans-Borgmeyer, I., O'Shea-Greenfield, A., Deneris, E.S., Moll, C., Borgmeyer, U., Hollmann, M., Heinemann, S., 1990. Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron 5, 583-595.
4. Bettler, B., Mulle, C., 1995. Neurotransmitter receptors II. AMPA and kainate receptors. Neuropharmacology 34, 123-139.
5. Bleakman, D., Ballyk, B.A., Schoepp, D.D., Palmer, A.J., Bath, C.P., Sharpe, E.F., Woolley, M.L., Bufton, H.R., Kamboj, R.K., Tarnawa, I., Lodge, D., 1996a. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology 35, 1689-1702.
6. Bleakman, D., Schoepp, D.D., Ballyk, B., Bufton, H., Sharpe, E.F., Thomas, K., Ornstein, P.L., Kamboj, R.K., 1996b. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S;4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3 carboxylic acid. Mol. Pharmacol. 49, 581-585.
7. Castillo, P.E., Malenka, R.C., Nicoll, R.A., 1997. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature 388, 182-188.
8. Chittajallu, R., Vignes, M., Dev, K.K., Barnes, J.M., Collingridge, G.L., Henley, J.M., 1996. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 379, 78-81.
9. Clarke, V.R.J., Ballyk, B.A., Hoo, K.H., Mandelzys, A., Pellizzari, A., Bath, C.P., Thomas, J., Sharpe, E.F., Davies, C.H., Ornstein, P.L., Schoepp, D.D., Kamboj, R.K., Collingridge, G.L., Lodge, D., Bleakman, D., 1997. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389, 599-603.
10. Davies, J., Evans, R.H., Francis, A.A., Watkins, J.C., 1979. Excitatory amino acid receptors and synaptic excitation in the mammalian central nervous system. J. Physiol. Paris 75, 641-654.
11. Donevan, S.D., Rogawski, M.A., 1993. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10, 51-59.
12. Foster, A.C., Mena, E.E., Monaghan, D.T., Cotman, C.W., 1981. Synaptic localization of kainic acid binding sites. Nature 289, 73-75.
13. Henley, J.M., 1994. Kainate-binding proteins: phylogeny, structures and possible functions. Trends Pharmacol. Sci. 15, 182-190.
14. Kehl, S.J., McLennan, H., Collingridge, G.L., 1984. Effects of folic and kainic acids on synaptic responses of hippocampal neurones. Neuroscience 11, 111-124.
15. Lauridsen, J., Honoré, T., Krogsgaard-Larson, P., 1985. Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors. J. Med. Chem. 28, 668-672.
16. McLennan, H., Lodge, D., 1979. The antagonism of amino acid-induced excitation of spinal neurones in the cat. Brain Res. 169, 83-90.
17. 3H]kainic acid binding sites in rat CNS as determined by autoradiography. Brain Res. 252, 91-100.
18. 3H]Glutamate binding to kainate-, NMDA-, and AMPA-sensitive binding sites: an autoradiographic analysis. Brain Res. 340, 378-383.
19. Mulle, C., Sailer, A., Pérez-Otaño, I., Dickinson-Anson, H., Castillo, P.E., Bureau, I., Maron, C., Gage, F.H., Mann, J.R., Bettler, B., Heinemann, S.F., 1998. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392, 601-605.
20. Nadler, J., 1978. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 271, 676-677.
21. Palmer, A.J., Lodge, D., 1993. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. Eur. J. Pharmacol. 244, 193-194.
22. Partin, K.M., Mayer, M.A., 1996. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655. Mol. Pharmacol. 49, 142-148.
23. Paternain, A.V., Morales, M., Lerma, J., 1995. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14, 185-189.
24. Represa, A., Tremblay, E., Ben-Ari, Y., 1987. Kainate binding sites in hippocampal mossy fibres: localisation and plasticity. Neuroscience 20, 739-748.
25. Robinson, J.H., Deadwyler, S.A., 1981. Kainic acid produces depolarization of CA3 pyramidal cells in the in vitro hippocampal slice. Brain Res. 221, 117-127.
26. Rodríguez-Moreno, A., Herreras, O., Lerma, J., 1997. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus. Neuron 19, 893-901.
27. Rodríguez-Moreno, A., Lerma, J., 1998. Kainate receptor modulation of GABA release involves a metabotropic function. Neuron 20, 1211-1218.
28. Salin, P.A., Scanziani, M., Malenka, R.C., Nicoll, R.A., 1996. Distinct short-term plasticity at two excitatory synapses in the hippocampus. Proc. Natl. Acad. Sci. USA 93, 13304-13309.
29. Sawada, S., Higashima, M., Yamamoto, C., 1985. Inhibitors of high-affinity uptake augment depolarisations of hippocampal neurons induced by glutamate, kainate and related compounds. Exp. Brain Res. 60, 323-329.
30. Sloviter, R.S., Damiano, B.P., 1981. On the relationship between kainic acid-induced epileptiform activity and hippocampal neuronal damage. Neuropharmacology 20, 1003-1011.
31. Tarnawa, I., Engeberg, I., Flatman, J.A., 1990. GYKI 52466, an inhibitor of spinal reflexes is a potent quisqualate antagonist. In: Lubec, G., Rosenthal, G.A. (Eds.), Amino Acids, Chemistry, Biology and Medicine. ESCOM, Leiden, pp. 538-544.
32. Vignes, M., Collingridge, G.L., 1997. The synaptic activation of kainate receptors. Nature 388, 179-182.
33. Vignes, M., Mathiesen, C., Collingridge, G.L., 1996. Activation of a kainate-induced inward current in CA3 hippocampal neurons of immature rats in vitro. J. Physiol. 495.P, 44P.
34. Vignes, M., Bleakman, D., Lodge, D., Collingridge, G.L., 1997. The synaptic activation of the GluR5 subtype of kainate receptor in area CA3 of the rat hippocampus. Neuropharmacology 36, 1477-1481.
35. Watkins, J.C., Evans, R.H., 1981. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 21, 165-204.
36. Westbrook, G.L., Lothman, E.W., 1983. Cellular and synaptic basis of kainic acid-induced hippocampal epileptiform activity. Brain Res. 273, 97-109.
37. Wilding, T.J., Huettner, J.E., 1995. Differential antagonism of alpha-amino-3-hydroxy-4-isoxazolepropionic acid-and kainate-preferring glutamate receptors by 2,3-benzodiazepines. Mol. Pharmacol. 47, 582-587.
38. Wisden, W., Seeburg, P.H., 1993. A complex mosaic of high affinity kainate receptors in rat brain. J. Neurosci. 13, 3582-3598.
39. Zorumski, C.F., Yamada, K.A., Price, M.T., Olney, J.W., 1993. GYKI 52466, a 2,3-benzodiazepine, as a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10, 51-59.